tirzepatide function Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Benefits of Tirzepatide Injections |

Tirzepatide (Zepbound) - FDA Approved 2023: According to clinical trials cited by multiple sources including NBC News, tirzepatide (a GIP/GLP-1 dual agonist) showed approximately 21% to 22.5% mean weight loss on its highest dose after 72 weeks, compared to approximately 3% for placebo

It takes patience and typically requires the help of a doctor, a dietitian, and an exercise physiologist, says Dr

Bring it up at a monitoring appointment if youre curious whether it makes sense for your situation

And critically, it needs to be effective at very low doses because even with skin-penetration enhancers, you're rarely getting more than a few milligrams across in 24 hours